White Rose University Consortium logo
University of Leeds logo University of Sheffield logo York University logo

Drugs for exceptionally rare diseases: a commentary on Hughes et al

Claxton, K., McCabe, C., Tsuchiya, A. and Raftery, J. (2006) Drugs for exceptionally rare diseases: a commentary on Hughes et al. Discussion Paper. QJM

This is the latest version of this eprint.

Full text available as:
[img] Text (HEDS_DP_06-02.pdf)
HEDS_DP_06-02.pdf

Download (294Kb)

Abstract

Recently in this journal, Hughes and colleagues discussed special funding status to ultra-orphan drugs. They concluded that there should be a uniform policy for the provision of orphan drugs across Europe; that complete restriction was impractical, and that UK policy should aspire to the values of the EU directive on orphan drugs. We critically assess these arguments, demonstrating that they failed to justify special status for treatments for rare diseases.

Item Type: Monograph (Discussion Paper)
Academic Units: The University of York > Economics and Related Studies (York)
Depositing User: ScHARR / HEDS (Sheffield)
Date Deposited: 14 Jul 2010 15:42
Last Modified: 17 Oct 2013 15:37
Status: Published
Publisher: QJM
Refereed: No
URI: http://eprints.whiterose.ac.uk/id/eprint/11032

Available Versions of this Item

Actions (login required)

View Item View Item